全文获取类型
| 收费全文 | 10971篇 |
| 免费 | 776篇 |
| 国内免费 | 43篇 |
专业分类
| 耳鼻咽喉 | 79篇 |
| 儿科学 | 195篇 |
| 妇产科学 | 195篇 |
| 基础医学 | 1566篇 |
| 口腔科学 | 252篇 |
| 临床医学 | 1055篇 |
| 内科学 | 2251篇 |
| 皮肤病学 | 147篇 |
| 神经病学 | 1182篇 |
| 特种医学 | 701篇 |
| 外科学 | 1882篇 |
| 综合类 | 46篇 |
| 一般理论 | 2篇 |
| 预防医学 | 472篇 |
| 眼科学 | 211篇 |
| 药学 | 704篇 |
| 中国医学 | 19篇 |
| 肿瘤学 | 831篇 |
出版年
| 2023年 | 102篇 |
| 2022年 | 212篇 |
| 2021年 | 436篇 |
| 2020年 | 234篇 |
| 2019年 | 280篇 |
| 2018年 | 369篇 |
| 2017年 | 262篇 |
| 2016年 | 402篇 |
| 2015年 | 431篇 |
| 2014年 | 534篇 |
| 2013年 | 592篇 |
| 2012年 | 906篇 |
| 2011年 | 798篇 |
| 2010年 | 485篇 |
| 2009年 | 435篇 |
| 2008年 | 684篇 |
| 2007年 | 622篇 |
| 2006年 | 557篇 |
| 2005年 | 518篇 |
| 2004年 | 464篇 |
| 2003年 | 438篇 |
| 2002年 | 350篇 |
| 2001年 | 131篇 |
| 2000年 | 131篇 |
| 1999年 | 150篇 |
| 1998年 | 75篇 |
| 1997年 | 52篇 |
| 1996年 | 44篇 |
| 1995年 | 50篇 |
| 1994年 | 42篇 |
| 1993年 | 28篇 |
| 1992年 | 105篇 |
| 1991年 | 93篇 |
| 1990年 | 71篇 |
| 1989年 | 88篇 |
| 1988年 | 76篇 |
| 1987年 | 64篇 |
| 1986年 | 62篇 |
| 1985年 | 66篇 |
| 1984年 | 34篇 |
| 1983年 | 33篇 |
| 1981年 | 21篇 |
| 1979年 | 21篇 |
| 1977年 | 24篇 |
| 1976年 | 20篇 |
| 1975年 | 19篇 |
| 1973年 | 18篇 |
| 1972年 | 15篇 |
| 1970年 | 17篇 |
| 1969年 | 20篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
1.
2.
3.
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma
4.
Stefan Scholz Florian Koerber Kinga Meszaros Rosa Maya Fassbender Bernhard Ultsch Robert R. Welte Wolfgang Greiner 《Vaccine》2019,37(12):1692-1701
Introduction
Invasive meningococcal disease (IMD) is a severe disease mainly affecting infants and young children. The most common serogroup causing IMD in Germany is the serogroup type B Neisseria meningitidis (MenB). The aim of the present study is to estimate the economic burden of MenB-related IMD in Germany.Method
A bottom-up, model-based costing approach has been used to calculate the diagnose- and age-specific yearly lifetime costs of a hypothetical cohort of MenB-related IMD cases. Direct costs contain the treatment cost for the acute phase of the disease, long-term sequelae, costs for rehabilitation, and public health response. Indirect costs are calculated for the human-capital approach and the friction-cost approach considering productivity losses of patients or parents for the acute phase and long-term sequelae. Publicly available databases from the Federal Statistical Office, the SOEP panel data set, literature, and expert opinion were used as data sources. All future costs beyond the reference year of 2015 were discounted at 3%.Results
The total costs for the hypothetical cohort (343 patients) from a societal perspective are €19.6 million (€57,100/IMD case) using the friction-cost approach and €58.8 million (€171,000/IMD case) using the human-capital approach. Direct costs amount to €18.6 million or €54,300 €/case. Sequelae are responsible for 81% of the direct costs/case.Discussion
The elevated costs/MenB-related IMD case reflect the severity of the disease. The total costs are sensitive to the productivity-loss estimation approach applied. MenB is an uncommon but severe disease; The costs/case reflect the severity of the disease and is within the same magnitude as for human papilloma virus infections. The available literature on sequelae is due to the uncommonness limited and heterogeneous. 相似文献5.
6.
B. Midouni E. Mehiri A. Ghariani H. Draoui L. Essalah I. Bouzouita D. Raoult L. Slim-Saidi P.E. Fournier 《International journal of antimicrobial agents》2019,53(1):63-69
Objectives
This study aimed to explore the genetic diversity of Streptococcus pneumoniae isolates in a Tunisian pneumology hospital.Methods
A total of 141 S. pneumoniae strains isolated between 2009–2016 in the microbiology laboratory at A. Mami Hospital of Pneumology were investigated. Antimicrobial susceptibility testing was performed the disk diffusion method. MICs of penicillin G, amoxicillin and cefotaxime were determined by Etest. Serotyping was inferred from the results of multiplex PCR targeting 40 serotypes. Sequence types (STs) were determined by multilocus sequence typing (MLST).Results
Among the 141 S. pneumoniae isolates, 98 (69.5%) were resistant to erythromycin. Evaluation of β-lactam susceptibility showed that 90 strains (63.8%) were non-susceptible to penicillin, whereas 48 (34.0%) had decreased susceptibility to amoxicillin and 21 (14.9%) to cefotaxime. Twenty-five serotypes were detected, and 10 isolates were classified as non-typeable. Vaccine coverage was 56.7%, 60.3% and 75.2% for pneumococcal conjugate vaccine 7 (PCV7), PCV10 and PCV13, respectively. Overall, 73 STs were identified, including 23 described for the first time. The most frequent STs were ST179 (n?=?17), ST3772 (n?=?14), ST2918 (n?=?10) and ST4003 (n?=?5), related to serotypes 19F, 19A, 14 and 23F, respectively. Moreover, 110 strains were classified within 45 STs. Three international antimicrobial-resistant clones were found, including Denmark14-ST230 (n?=?22), Spain9V-ST156 (n?=?22) and Portugal19F-ST177 (n?=?20).Conclusion
This study emphasises the clonal and international dissemination of antimicrobial-resistant S. pneumoniae clones. Significant differences in genetic variation were documented by MLST within the various serotypes identified. 相似文献7.
8.
9.
10.
Lesley A. Inker Morgan E. Grams Andrew S. Levey Josef Coresh Massimo Cirillo John F. Collins Ron T. Gansevoort Orlando M. Gutierrez Takayuki Hamano Gunnar H. Heine Shizukiyo Ishikawa Sun Ha Jee Florian Kronenberg Martin J. Landray Katsuyuki Miura Girish N. Nadkarni Carmen A. Peralta Dietrich Rothenbacher Mark Woodward 《American journal of kidney diseases》2019,73(2):206-217